Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Viscount Stansgate, and are more likely to reflect personal policy preferences.
Viscount Stansgate has not introduced any legislation before Parliament
Viscount Stansgate has not co-sponsored any Bills in the current parliamentary sitting
The Government has no plans to amend the Regency Act.
The Royal Prerogative is the residual power inherent in the Sovereign, and which is now exercised mostly on the advice of Ministers. It may be divided into the following broad categories: constitutional or personal prerogatives and prerogative executive powers.
The Dissolution and Calling of Parliament Bill, which is currently going through your Lordship’s House, will make the Royal Prerogative powers relating to the dissolution of Parliament and the calling of a new Parliament exercisable again, as if the Fixed-term Parliaments Act 2011 had never been enacted. We have a sound legal basis for the position that prerogative powers can be revived, and there is no doubt on this question if this is made clear in statute. Clause 2 of the Bill makes the necessary express provision accordingly.
Parliament can and has legislated to modify, abolish, or supersede Royal Prerogative powers. It is rare that statutes abolish Royal Prerogative powers explicitly. It is, therefore, a matter of legal judgement whether a prerogative is abridged by implication.
The Royal Prerogative is the residual power inherent in the Sovereign, and which is now exercised mostly on the advice of Ministers. It may be divided into the following broad categories: constitutional or personal prerogatives and prerogative executive powers.
The Dissolution and Calling of Parliament Bill, which is currently going through your Lordship’s House, will make the Royal Prerogative powers relating to the dissolution of Parliament and the calling of a new Parliament exercisable again, as if the Fixed-term Parliaments Act 2011 had never been enacted. We have a sound legal basis for the position that prerogative powers can be revived, and there is no doubt on this question if this is made clear in statute. Clause 2 of the Bill makes the necessary express provision accordingly.
Parliament can and has legislated to modify, abolish, or supersede Royal Prerogative powers. It is rare that statutes abolish Royal Prerogative powers explicitly. It is, therefore, a matter of legal judgement whether a prerogative is abridged by implication.
The Royal Prerogative is the residual power inherent in the Sovereign, and which is now exercised mostly on the advice of Ministers. It may be divided into the following broad categories: constitutional or personal prerogatives and prerogative executive powers.
The Dissolution and Calling of Parliament Bill, which is currently going through your Lordship’s House, will make the Royal Prerogative powers relating to the dissolution of Parliament and the calling of a new Parliament exercisable again, as if the Fixed-term Parliaments Act 2011 had never been enacted. We have a sound legal basis for the position that prerogative powers can be revived, and there is no doubt on this question if this is made clear in statute. Clause 2 of the Bill makes the necessary express provision accordingly.
Parliament can and has legislated to modify, abolish, or supersede Royal Prerogative powers. It is rare that statutes abolish Royal Prerogative powers explicitly. It is, therefore, a matter of legal judgement whether a prerogative is abridged by implication.
We can confirm that Sir Jeremy has stood down from the Covid SAGE activation. SAGE continues to provide the Government with independent expert scientific and technical advice.
We continue to monitor US Aviation industry concerns that the US 5G network could affect equipment onboard aircraft.
The UK Civil Aviation Authority (CAA) is leading on assessing any risks from the implementation of the UK 5G network on aviation safety, in conjunction with the Ministry of Defence, OFCOM, and industry stakeholders. The CAA has issued guidance to UK operators throughout the world on 5G status in other countries, including the US.
The UK CAA will continue to monitor the situation, and both my department and the CAA is in close contact with industry, the US Federal Aviation Administration, the EU Aviation Safety Agency and other stakeholders on this.
Whilst no formal assessment has been made, we have noted the Charter’s focus on quality standards of care, access to accurate information and equality.
Allergy services in England are commissioned through clinical commissioning groups to meet the needs of the local population. A small number of specialist allergy services for patients with rare and complex conditions are commissioned through NHS England and NHS Improvement’s specialised commissioning. The service specification specifies that centres provide equity of access to best practice standards for diagnosis and management, based on current national and international guidelines.
The Department and NHS England and NHS Improvement continue to engage with stakeholders to understand the needs of people with allergies and how services could be improved. This includes patient and public voice membership in NHS England and NHS Improvement’s clinical reference group which provides clinical advice and leadership on specialised immunology and allergy services.
The Therapeutics Taskforce is monitoring data from clinical trials taking place worldwide to assess whether ivermectin is a safe and effective treatment for COVID-19. Ivermectin is not currently a licensed treatment for COVID-19 and evidence from clinical trials as a treatment for COVID-19 is inconclusive. This assessment is based on the views of the Therapeutics Taskforce, the UK COVID-19 Therapeutics Advisory Panel and the Research to access pathway for investigational drugs for COVID-19. This assessment is also consistent with the views of the World Health Organization, the Food and Drug Administration and the European Medicines Agency. We will continue to keep this assessment under review as more data becomes available from clinical trials, including the Government-funded PRINCIPLE clinical trial.
The NHS COVID Pass can now be used to demonstrate proof of a booster or third dose for outbound international travel. This is visible through the NHS App and NHS.UK within the NHS COVID Pass for Travel.